News
There are currently no news stories available for this symbol.
RELATED RESOURCES |
Snapshot: XDNAKELLY CRISPR & GENE EDITING TECHNOLOGY ETF9.232 as of 4:15:00pm ET 06/01/2023
Quotes delayed at least 15 min.
Log in for real time quote.
|
ETP TypeETF Net Assets
|
30-day SEC Yield AS OF -- | -- |
---|---|
Distribution Yield (TTM) AS OF 04/28/2023 |
0.10% |
XDNA KELLY CRISPR & GENE EDITING TECHNOLOGY ETF |
Asset Class Median | |
---|---|---|
Volume (10-Day Avg) AS OF 05/31/2023 |
1.1K | 16.8M |
1 Month Market Total Return AS OF 05/31/2023 |
+1.89 | -2.58% |
1 Year Market Total Return AS OF 04/30/2023 |
-10.01 | -2.68% |
3 Year Annualized Market Total Return AS OF 04/30/2023 |
-- | +11.34% |
Beta (1 Year Month-End) AS OF 05/31/2023 |
0.69% | 1.10 |
Annual Turnover Ratio AS OF -- |
-- | 30.00% |
Net Expense Ratio AS OF 12/29/2022 |
0.78% | 0.51% |
NAV Return | Market Return | |
---|---|---|
1 Year | -28.35 | -29.13 |
3 Year | -- | -- |
5 Year | -- | -- |
10 Year | -- | -- |
Life | -33.85 | -33.88 |
The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.
More about Performance & RiskTMO | Thermo Fisher Scientific Inc | 11.66% |
---|---|---|
CRISPR Therapeutics AG | 11.33% | |
NTLA | Intellia Therapeutics Inc | 10.73% |
BEAM | Beam Therapeutics Inc | 8.72% |
ABBV | AbbVie Inc | 5.13% |
EDIT | Editas Medicine Inc | 4.64% |
ALLO | Allogene Therapeutics Inc | 4.40% |
PRME | Prime Medicine Inc | 4.31% |
VERV | Verve Therapeutics Inc | 4.31% |
Novartis AG Registered Shares | 4.03% |
Commentary